Company · CIK 0001656328 · SIC 2834 — Pharmaceutical Preparations
Sienna Biopharmaceuticals, Inc. · SNNA
Insider activity reported against this company. All insider holders · On EDGAR ↗
Reported at this company — common stock
| Trade | Reported (ET) | Insider | Shares | Avg price | Total | Owned after | Δ stake | Flags |
|---|---|---|---|---|---|---|---|---|
| Feb 22, 2019 PForm 4 → | Feb 26, 9:08 pm EST | ARCH Venture Partners X, LLC +510% Owner | 2,165,800 | $2.50 | $5,414,500 | 1,865,800 | — | plan? |
| Feb 22, 2019 PForm 4 → | Feb 26, 9:06 pm EST | ARCH Venture Partners VIII, LLC +610% Owner | 2,165,800 | $2.50 | $5,414,500 | 1,865,800 | — | plan? |
| Feb 22, 2019 PForm 4 → | Feb 26, 9:03 pm EST | Kristina BurowDirector | 2,165,800 | $2.50 | $5,414,500 | 1,865,800 | — | plan? |
| Feb 22, 2019 PForm 4 → | Feb 26, 5:16 pm EST | Robert J MoreDirector | 100,000 | $2.50 | $250,000 | 255,942 | +64.1% | plan? |
| Feb 22, 2019 PForm 4 → | Feb 26, 5:14 pm EST | Keith R LeonardDirector | 100,000 | $2.50 | $250,000 | 100,000 | — | plan? |
| Feb 22, 2019 PForm 4 → | Feb 26, 5:12 pm EST | III Frederick BeddingfieldPresident & CEO, Director | 40,000 | $2.50 | $100,000 | 831,662 | +5.05% | plan? |
| Jan 1, 2019 AForm 4 → | Jan 3, 6:21 pm EST | Diane StroehmannSee Remarks | 45,000 | — | — | 172,640 | — | plan? |
| Jan 1, 2019 AForm 4 → | Jan 3, 6:19 pm EST | John W SmitherChief Financial Officer | 45,000 | — | — | 46,657 | — | plan? |
| Jan 1, 2019 AForm 4 → | Jan 3, 6:16 pm EST | Paul F. LizzulChief Medical Officer | 45,000 | — | — | 142,583 | — | plan? |
| Jan 1, 2019 AForm 4 → | Jan 3, 6:13 pm EST | Timothy K. AndrewsGeneral Counsel & Secretary | 45,000 | — | — | 99,653 | — | plan? |
| Jan 1, 2019 AForm 4 → | Jan 3, 6:11 pm EST | III Frederick BeddingfieldPresident & CEO, Director | 187,500 | — | — | 791,662 | — | plan? |
| May 17, 2018 JForm 4 → | May 21, 9:05 am EDT | III Frederick BeddingfieldPresident & CEO, Director | 47,594 | — | — | 601,246 | — | plan? |
| Apr 30, 2018 SForm 4 → | May 2, 7:54 pm EDT | Todd HarrisHead of Corporate Development, Director | 100 | $20.00 | $2,000 | 570,991 | −0.02% | plan? |
| Apr 23, 2018 SForm 4 → | Apr 25, 7:21 pm EDT | Todd HarrisHead of Corporate Development, Director | 975 | $20.00 | $19,500 | 571,091 | −0.17% | plan? |
| Apr 17, 2018 SForm 4 → | Apr 19, 6:00 pm EDT | Todd HarrisHead of Corporate Development, Director | 18,011 | $20.08 | $361,619 | 572,066 | −3.05% | plan? |
| Apr 10, 2018 SForm 4 → | Apr 12, 6:45 pm EDT | Todd HarrisHead of Corporate Development, Director | 3,779 | $20.02 | $75,641 | 590,077 | −0.64% | plan? |
| Apr 5, 2018 SForm 4 → | Apr 9, 7:18 pm EDT | Todd HarrisHead of Corporate Development, Director | 8,210 | $20.00 | $164,205 | 593,856 | −1.36% | plan? |
| Mar 28, 2018 SForm 4 → | Mar 29, 8:50 pm EDT | Robert J MoreDirector | 24,429 | $18.80 | $459,377 | 178,820 | −12.0% | plan? |
| Mar 19, 2018 SForm 4 → | Mar 20, 7:00 pm EDT | Todd HarrisHead of Corporate Development, Director | 5,876 | $20.00 | $117,520 | 602,066 | −0.97% | plan? |
| Mar 12, 2018 SForm 4 → | Mar 14, 7:13 pm EDT | Todd HarrisHead of Corporate Development, Director | 3,452 | $20.11 | $69,429 | 607,942 | −0.56% | plan? |
| Mar 7, 2018 SForm 4 → | Mar 9, 7:00 pm EST | Todd HarrisHead of Corporate Development, Director | 20,672 | $20.03 | $413,961 | 611,394 | −3.27% | plan? |
| Sep 18, 2017 PForm 4 → | Sep 19, 11:56 am EDT | Dennis M FentonDirector | 1,250 | $22.96 | $28,698 | 1,250 | — | plan? |
| Aug 1, 2017 CForm 4 → | Aug 1, 4:30 pm EDT | ARCH Venture Partners VIII, LLC +510% Owner | 3,633,068 | — | — | 882,493 | — | plan? |
| Aug 1, 2017 PForm 4 → | Aug 1, 4:27 pm EDT | Diane StroehmannSee Remarks | 7,000 | $15.00 | $105,000 | 124,724 | +5.95% | plan? |
| Aug 1, 2017 CForm 4 → | Aug 1, 4:27 pm EDT | Diane StroehmannSee Remarks | 28,153 | — | — | 117,724 | — | plan? |
| Aug 1, 2017 PForm 4 → | Aug 1, 4:26 pm EDT | Richard D PetersonChief Financial Officer | 7,000 | $15.00 | $105,000 | 7,000 | — | plan? |
| Aug 1, 2017 CForm 4 → | Aug 1, 4:25 pm EDT | Robert NelsenDirector, 10% Owner | 3,633,068 | — | — | 882,493 | — | plan? |
| Aug 1, 2017 CForm 4 → | Aug 1, 4:24 pm EDT | Robert J MoreDirector | 169,178 | — | — | 203,249 | — | plan? |
| Aug 1, 2017 PForm 4 → | Aug 1, 4:24 pm EDT | Erle T MastDirector | 6,700 | $15.00 | $100,500 | 6,700 | — | plan? |
| Aug 1, 2017 PForm 4 → | Aug 1, 4:23 pm EDT | Paul F. LizzulChief Medical Officer | 10,000 | $15.00 | $150,000 | 94,634 | +11.8% | plan? |
| Aug 1, 2017 CForm 4 → | Aug 1, 4:23 pm EDT | Paul F. LizzulChief Medical Officer | 10,557 | — | — | 10,557 | — | plan? |
| Aug 1, 2017 PForm 4 → | Aug 1, 4:22 pm EDT | Keith R LeonardDirector | 16,700 | $15.00 | $250,500 | 16,700 | — | plan? |
| Aug 1, 2017 CForm 4 → | Aug 1, 4:22 pm EDT | Keith R LeonardDirector | 31,784 | — | — | 31,784 | — | plan? |
| Aug 1, 2017 CForm 4 → | Aug 1, 4:21 pm EDT | Kristina BurowDirector | 3,633,068 | — | — | 882,493 | — | plan? |
| Aug 1, 2017 CForm 4 → | Aug 1, 4:20 pm EDT | III Frederick BeddingfieldPresident & CEO, Director | 140,766 | — | — | 112,614 | — | plan? |
| Aug 1, 2017 PForm 4 → | Aug 1, 4:19 pm EDT | Timothy K. AndrewsGeneral Counsel & Secretary | 15,000 | $15.00 | $225,000 | 15,000 | — | plan? |
Reported at this company — derivatives (options, RSUs, warrants)
| Trade | Reported (ET) | Insider | Shares | Avg price | Total | Owned after | Δ stake | Flags |
|---|---|---|---|---|---|---|---|---|
| Jan 1, 2019 AForm 4 → | Jan 3, 6:21 pm EST | Diane StroehmannSee Remarks | 59,632 | — | — | 45,000 | — | |
| Jan 1, 2019 AForm 4 → | Jan 3, 6:19 pm EST | John W SmitherChief Financial Officer | 59,422 | — | — | 45,000 | — | |
| Jan 1, 2019 AForm 4 → | Jan 3, 6:16 pm EST | Paul F. LizzulChief Medical Officer | 59,904 | — | — | 45,000 | — | |
| Jan 1, 2019 AForm 4 → | Jan 3, 6:13 pm EST | Timothy K. AndrewsGeneral Counsel & Secretary | 63,290 | — | — | 45,000 | — | |
| Jan 1, 2019 AForm 4 → | Jan 3, 6:11 pm EST | III Frederick BeddingfieldPresident & CEO, Director | 228,468 | — | — | 187,500 | — | |
| Aug 1, 2018 AForm 4 → | Aug 3, 5:53 pm EDT | James M. HindmanDirector | 20,000 | — | — | 20,000 | — | |
| Jul 15, 2018 AForm 4 → | Jul 17, 8:36 pm EDT | John W SmitherChief Financial Officer | 20,000 | — | — | 20,000 | — | |
| Jun 1, 2018 AForm 4 → | Jun 5, 9:25 am EDT | Robert NelsenDirector, 10% Owner | 10,000 | — | — | 10,000 | — | |
| Jun 1, 2018 AForm 4 → | Jun 5, 9:23 am EDT | Kristina BurowDirector | 10,000 | — | — | 10,000 | — | |
| Jun 1, 2018 AForm 4 → | Jun 4, 9:43 pm EDT | Robert J MoreDirector | 10,000 | — | — | 10,000 | — | |
| Jun 1, 2018 AForm 4 → | Jun 4, 9:42 pm EDT | Erle T MastDirector | 10,000 | — | — | 10,000 | — | |
| Jun 1, 2018 AForm 4 → | Jun 4, 9:41 pm EDT | Dennis M FentonDirector | 10,000 | — | — | 10,000 | — | |
| Jun 1, 2018 AForm 4 → | Jun 4, 9:40 pm EDT | Keith R LeonardDirector | 10,000 | — | — | 10,000 | — | |
| Jun 1, 2018 AForm 4 → | Jun 4, 9:32 pm EDT | Diane StroehmannSee Remarks | 48,720 | — | — | 48,720 | — | |
| Jun 1, 2018 AForm 4 → | Jun 4, 9:28 pm EDT | Paul F. LizzulChief Medical Officer | 48,720 | — | — | 48,720 | — | |
| Jun 1, 2018 AForm 4 → | Jun 4, 9:23 pm EDT | Timothy K. AndrewsGeneral Counsel & Secretary | 60,000 | — | — | 60,000 | — | |
| Jun 1, 2018 AForm 4 → | Jun 4, 9:21 pm EDT | III Frederick BeddingfieldPresident & CEO, Director | 190,910 | — | — | 190,910 | — | |
| Apr 16, 2018 AForm 4 → | Apr 18, 6:31 pm EDT | John W SmitherChief Financial Officer | 170,000 | — | — | 170,000 | — | |
| Nov 1, 2017 AForm 4 → | Nov 2, 11:52 am EDT | Robert NelsenDirector, 10% Owner | 5,315 | — | — | 5,315 | — | |
| Nov 1, 2017 AForm 4 → | Nov 2, 11:51 am EDT | Keith R LeonardDirector | 5,315 | — | — | 5,315 | — | |
| Nov 1, 2017 AForm 4 → | Nov 2, 11:50 am EDT | Kristina BurowDirector | 5,315 | — | — | 5,315 | — | |
| Aug 1, 2017 CForm 4 → | Aug 1, 4:30 pm EDT | ARCH Venture Partners VIII, LLC +510% Owner | 3,633,068 | — | — | 0 | — | |
| Aug 1, 2017 CForm 4 → | Aug 1, 4:27 pm EDT | Diane StroehmannSee Remarks | 28,153 | — | — | 0 | — | |
| Aug 1, 2017 CForm 4 → | Aug 1, 4:25 pm EDT | Robert NelsenDirector, 10% Owner | 3,633,068 | — | — | 0 | — | |
| Aug 1, 2017 CForm 4 → | Aug 1, 4:24 pm EDT | Robert J MoreDirector | 169,178 | — | — | 0 | — | |
| Aug 1, 2017 CForm 4 → | Aug 1, 4:23 pm EDT | Paul F. LizzulChief Medical Officer | 10,557 | — | — | 0 | — | |
| Aug 1, 2017 CForm 4 → | Aug 1, 4:22 pm EDT | Keith R LeonardDirector | 31,784 | — | — | 0 | — | |
| Aug 1, 2017 CForm 4 → | Aug 1, 4:21 pm EDT | Kristina BurowDirector | 3,633,068 | — | — | 0 | — | |
| Aug 1, 2017 CForm 4 → | Aug 1, 4:20 pm EDT | III Frederick BeddingfieldPresident & CEO, Director | 140,766 | — | — | 0 | — | |
| Jul 26, 2017 AForm 4 → | Jul 27, 4:27 pm EDT | Diane StroehmannSee Remarks | 11,926 | — | — | 11,926 | — | |
| Jul 26, 2017 AForm 4 → | Jul 27, 4:26 pm EDT | Richard D PetersonChief Financial Officer | 8,518 | — | — | 8,518 | — | |
| Jul 26, 2017 AForm 4 → | Jul 27, 4:26 pm EDT | Paul F. LizzulChief Medical Officer | 11,926 | — | — | 11,926 | — | |
| Jul 26, 2017 AForm 4 → | Jul 27, 4:25 pm EDT | Todd HarrisHead of Corporate Development, Director | 11,926 | — | — | 11,926 | — | |
| Jul 26, 2017 AForm 4 → | Jul 27, 4:24 pm EDT | III Frederick BeddingfieldPresident & CEO, Director | 42,590 | — | — | 42,590 | — | |
| Jul 26, 2017 AForm 4 → | Jul 27, 4:23 pm EDT | Timothy K. AndrewsGeneral Counsel & Secretary | 8,518 | — | — | 8,518 | — |